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It is known that the circadian rhythm in hepatic phosphoenolpyruvate carboxykinase expression
(a limiting catalytic stepofgluconeogenesis) andhepatic glucoseproduction ismaintainedbyboth
daily oscillation in autonomic inputs to the liver and night feeding behavior. However, increased
glycemia and reduced melatonin (Mel) levels have been recently shown to coexist in diabetic
patients at the end of the night period. In parallel, pinealectomy (PINX) is known to cause glucose
intolerancewith increased basal glycemia exclusively at the end of the night. Themechanisms that
underlie this metabolic feature are not completely understood. Here, we demonstrate that PINX
rats show night-time hepatic insulin resistance characterized by reduced insulin-stimulated RAC-
serine/threonine-protein kinase phosphorylation and increased phosphoenolpyruvate carboxyki-
nase expression. In addition, PINX rats display increased conversion of pyruvate into glucose at the
end of the night. The regulatory mechanism suggests the participation of unfolded protein response
(UPR), because PINX induces night-time increase in activating transcription factor 6 expression and
prompts a circadian fashion of immunoglobulin heavy chain-binding protein, activating transcription
factor 4, and CCAAT/enhancer-binding protein-homologous protein expression with Zenith values at
the dark period. PINX also caused a night-time increase in Tribble 3 and regulatory-associated protein
ofmammaliantargetofrapamycin;bothwerereducedinliverofPINXratstreatedwithMel.Treatment
of PINX rats with 4-phenyl butyric acid, an inhibitor of UPR, restored night-time hepatic insulin sensi-
tivity and abrogated gluconeogenesis in PINX rats. Altogether, the present data show that a circadian
oscillation ofUPRoccurs in the liver due to the absence ofMel. The nocturnal UPR activation is related
with night-timehepatic insulin resistance and increased gluconeogenesis in PINX rats. (Endocrinology
152: 1253–1263, 2011)
Melatonin (Mel) production by pineal gland modu-lates carbohydrate metabolism in such way that pi-
nealectomy (PINX) leads to glucose intolerance and in-
sulin resistance (1). The impairment of insulin-induced
glucose uptake by adipocytes is one feature that accounts
for whole-body insulin resistance in PINX rats. Impor-
tantly, insulin resistance is detected in both phases of the
light-dark cycle (L/D cycle) (2). PINX also promotes a
dark period-specific increase in basal glycemia that is re-
versed by Mel reposition, irrespective of an ad libitum or
scheduled feeding regimen (3). Increased night-time glu-
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cose concentration in PINX rats occurs even in the pres-
ence of higher levels of insulin secretion at the night (4),
which suggests that an additional territory contributes
to the night time-related insulin resistance when Mel is
absent.
Ii is well known that the liver is a key organ that releases
glucose into the circulation by means of glycogenolysis
and gluconeogenesis, to maintain glycemia into a close
range. The limiting step of hepatic gluconeogenesis is the
enzymatic activity of phosphoenolpyruvate carboxyki-
nase (PEPCK), which expression is controlled by insulin
(5). In rats, a circadian rhythm in hepatic PEPCK expres-
sion and hepatic glucose production is maintained by both
daily oscillation in autonomic inputs to the liver and night
feeding behavior (6, 7). Pointing to a putative endocrine
control of circadian regulation of hepatic glucose produc-
tion, it has been demonstrated that diabetic patients show
increased gluconeogenesis and hyperglycemia during the
first morning hours, in parallel to decreased levels of cir-
culating Mel (8). Whether an alteration in circadian
rhythm of hepatic gluconeogenesis or PEPCK expression
contributes to the increased night-time hyperglycemia in-
duced by the absence of Mel remains to be determined.
During the last few years, it has become clear that the
endoplasmatic reticulum (ER) participates in the genesis
of diabetes by activating an unfolded protein response
(UPR) as a consequence of unfolded or misfolded protein
accumulation within the ER lumen (9). UPR activation has
been reported to induce both pancreatic -cell death and
insulin resistance (10–12). Importantly, short-term UPR
activation in the liver was shown to result in an increase in
glucose production (13, 14).
In the present study, we investigated the expression
profile of key intracellular mediators of the UPR through-
out the L/D cycle in the liver of sham-operated (SHAM)
and PINX rats supplemented or not with Mel. These pa-
rameters were assessed together with the expression and
activity of signaling proteins and metabolic enzymes clas-
sically correlated with the regulation of hepatic gluconeo-
genesis by insulin. Hepatic insulin resistance was assessed
by measuring the ability of insulin in acutely stimulate
RAC- serine/threonine-protein kinase (AKT) phosphor-
ylation, and gluconeogenesis was estimated by ip pyruvate
tolerance test (ipPTT).
Materials and Methods
Animals, surgical procedure, Mel supplementation,
and treatment with 4-phenyl butyric acid (PBA)
Wistar rats obtained from the Animal Breeding Center of the
Institute of Biomedical Sciences (Sao Paulo, Brazil) were kept
under strictly light cycle conditions (12-h light, 12-h dark cycle)
with free access to food and water. Seven-week-old rats were
anesthetized with ip injection of sodium thiopental (50 mg/kg
body weight) and subjected to PINX or to a SHAM, according
to the method previously described (15). Briefly, the anesthetized
animal was placed in a stereotaxic apparatus for small animals,
and a sagittal opening was made on the scalp. The skin and
muscles were pushed aside to expose the  suture. By means of
a circular drill, a disc-shaped perforation was made around the
, and the disc-shaped piece of bone was delicately removed.
Thereafter, the pineal gland (which is located just below the
posterior venous sinus confluence) was removed with a fine for-
ceps. Afterward, the skull was closed by returning the disc-
shaped bone, and the scalp was sutured with cotton thread.
After recovery from surgery, rats were provided with food
and water ad libitum (one animal per cage). A separated group
of animals submitted to PINX received nocturnal Mel (Sigma
Chemical Co., St. Louis, MO) reposition in the drinking water
(PINXMel) as previously described (16). Six weeks after sur-
gery, rats were euthanized at different Zeitgeber times (ZTs) (3,
6, and 9 h after lights on: ZT3, ZT6, and ZT9, respectively, and
0, 3, 6, 9, and 12 h after lights off: ZT12, ZT15, ZT18, ZT21,
and ZT24, respectively). After all experiments, effectiveness of
the PINX was verified by the macroscopic post mortem exam-
ination of the central nervous system to check for pineal absence.
PBA (Sigma-Aldrich, St. Louis, MO) was diluted in vehicle
[0.9% NaCl (wt/vol) and 0.15 mM NaHCO3] to a final concen-
tration of 100 mg/ml. PINX rats received PBA (PINXPBA) or
vehicle ip during 7 d prior the experimental procedure. In these
experiments, SHAM rats were treated with vehicle. PBA dosage
was 250 mg/Kg1d 1 injected at ZT12. All experiments were
conductedinaccordancewiththeguidelinesof theBrazilianCollege
for Animal Experimentation and were approved by the Institute of
Biomedical Sciences Ethics Committee for Animal Research.
Intraperitoneal PTT
Rats were fasted for 12 h, and a sodium pyruvate solution
(250 mg/ml) was injected ip at ZT24. The final dosage of pyru-
vate was 2 g/kg. Glucose was determined in blood extracted from
the tail before (0 min) and 15, 30, 60, 90, 120, and 150 min after
pyruvate injection. The area under the curve (AUC) glycemia vs.
time was calculated above each individual baseline (basal glyce-
mia) to estimate the total glucose synthesized from pyruvate.
Control experiments were performed in PINX and SHAM rats
with an oral administration of 3-mercaptopicolinic acid (3-mpa)
(30 mg/kg), an inhibitor of gluconeogenesis, 30 min before py-
ruvate injection.
RNA extraction and RT-PCR
Total RNA was extracted from approximately 100 mg of
liver of SHAM and PINX rats using Trizol reagent (Invitrogen,
Carlsbad, CA). Total RNA was reverse transcribed for both end-
point and real-time PCR. End-point PCR was performed as pre-
viously described (17). The amplification products were run on
a 1.0% agarose gel containing ethidium bromide, and band in-
tensities were determined by digital scanning followed by quan-
tification using the Scion Image analysis software (Scion Corp.,
Frederick, MD). The results were expressed as a ratio of the
target genes by the housekeeping ribosomal protein L37a. The
primer sequences used for end-point RT-PCR analysis with their
respective annealing temperature are described in Supplemental
Table 1, published on The Endocrine Society’s Journals Online
web site at http://endo.endojournals.org.
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Real-time PCR was performed to detect Tribble 3 (trb3), reg-
ulatory-associated protein of mammalian target of rapamycin
(mTOR) (raptor), pepck, and forkhead box protein O1 (foxo1)
mRNA expression using Stratagene Mx4000 equipment (Agi-
lent Technologies, Santa Clara, CA) and Sybr Green as fluores-
cent dye (Invitrogen). Primer sequences and annealing temper-
ature are described in Supplemental Table 2. Amplification
efficiency of each sample was calculated as previous described
(18), and relative gene expression was determined by the method
described by Liu and Saint (19) using ribosomal protein L37a as
inner control. All samples were compared using the relative cycle
threshold.
Protein extraction and immunoblotting
For insulin signaling experiments, rats were anesthetized with
sodium thiopental (5 mg/100 g body weight ip). The abdominal
cavity was opened, and a fragment of the liver was removed to
assess basal AKT phosphorylation. Next, the cava vein was ex-
posed and injected with 0.1 ml of a 104 M insulin solution. After
30 sec, an additional fragment of the liver was removed to assess
insulin-stimulated AKT phosphorylation. For protein expres-
sion and phosphorylation along the L/D cycle, rats were anes-
thetized, and a fragment of the liver was removed. Liver samples
were processed for Western blotting as previously described (17).
Primary antibodies used were: CCAAT/enhancer-binding pro-
tein-homologous protein (CHOP), activating transcription fac-
tor (ATF)4, phospho-AKT1/2/3 (Ser473), TRB3, PEPCK (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), AKT1, AKT2 (Up-
state Biotechnology, New York, NY), rapamycin-insensitive
companion of mTOR and RAPTOR (Cell Signaling Technology,
Lake Placid, NY), and phospho-eiF2 (Ser51) (Abcam, Cam-
bridge, MA). A secondary antibody conjugated with horseradish
peroxidase (Bio-Rad, Hercules, CA) was used followed by
chemiluminescent detection of the bands in x-ray sensitive films.
Optical densitometry of the films was performed using the Scion
Image analysis software (Scion Corp.).
Statistical analysis
Data are presented as mean  SE. Temporal variation along
the 24 h, for each group (SHAM and PINX), was evaluated using
one-way ANOVA with Tukey post hoc test, after checking for
normality of the data. Comparisons between the 24-h profiles
were performed using two-way ANOVA, considering as factors
“time of the day” (ZT) and “surgery” (SHAM and PINX groups)
followed by the Bonferroni post hoc test. Two-way ANOVA
followed by the Bonferroni was also used to compare SHAM,
PINX, and PINX treated with Mel within the same ZT.
The 24-h means for some variables of CTL and PINX groups
were compared either using standard t test or Mann-Whitney,
according to the results of D’Agostino-Pearson normality test.
All graphs and statistical tests were done using GraphPad Prism
version 5.03 for Windows (GraphPad Software, San Diego, CA).
Results
Body weight, adiposity, and food intake
Body weight and adiposity were equal between SHAM
and PINX rats. Mean body weight was 368.80 13.07 g
for SHAM and 366.30  19.30 g for PINX rats. Mean
adiposity (estimated by the ratio between periepididymal
fat depot and body weight) was 13.40  0.30 mg/g for
SHAM and 13.60  1.40 mg/g for PINX rats (Supple-
mental Table 3). Food intake was assessed during the light
and dark phases of L/D cycle. Values were equal for PINX
and SHAM in both diurnal and nocturnal periods (Sup-
plemental Fig. 1).
Nocturnal profile of AKT expression and
phosphorylation in liver of SHAM and PINX rats
AKT content and phosphorylation were assessed in
liver of SHAM and PINX rats at several points of the dark
phase and at a representative diurnal point (ZT6) of the
L/D cycle. Representative blots are shown in Fig. 1A.
AKT phosphorylation was reduced in PINX compared
with SHAM rats at ZT18 and at ZT21 (0.63- and 0.67-
fold of SHAM, respectively; P 0.05). The opposite pat-
tern was observed at ZT6, i.e. AKT phosphorylation in
PINX was 2.2-fold of that found in SHAM rats (P0.05).
In addition, PINX rats exhibited the highest levels of AKT
phosphorylation at ZT6 (2.03-fold of ZT18; P  0.05),
whereas SHAM exhibited it at ZT21 (1.80-fold of ZT24;
P  0.05) (Fig. 1B). Nocturnal Mel reposition restored
AKT phosphorylation in PINX liver at ZT18, reaching
values similar of that found in SHAM animals. Addition
of vehicle in drinking water did not interfere with the re-
duction of hepatic AKT phosphorylation in PINX rats
(0.73-fold of SHAM; P  0.05) (Fig. 1E).
AKT1 protein content was kept constant in both
SHAM and PINX rats during the same sampling points
(Fig. 1C). On the other hand, AKT2 expression showed
a circadian pattern. In SHAM animals it peaked at ZT6
(2.2-fold of SHAM at ZT24; P  0.05). In PINX rats,
maximal values were detected at ZT18 (1.7-fold of
SHAM; P  0.05) and lower levels at ZT15 (Fig. 1D).
PINX rats display hepatic insulin resistance and
increased gluconeogenesis at ZT24
A putative physiological significance for reduced AKT
phosphorylation was investigated by analyzing gluconeo-
genesis through ipPTT. Compared with SHAM, pyruvate
load induced a higher increase in blood glucose in PINX
rats (Fig. 2A). This response was significantly higher at 30,
60, 90, and 120 min after pyruvate injection and resulted
in 3.10-fold increase (P  0.05) in the AUC (Fig. 2B).
PINX rats treated with Mel exhibited glucose levels sim-
ilar to SHAM rats.
To verify if the increase in circulating glucose levels
after ipPTT were actually due to gluconeogenesis,
SHAM and PINX rats were previously treated with
3-mpa, an inhibitor of PEPCK. Pretreatment with
3-mpa completely inhibited the increase in glycemia in-
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duced by pyruvate in both PINX and SHAM animals
(Fig. 2A), assuring the gluconeogenic component of the
ascending curve.
Basal AKT phosphorylation was similar in SHAM and
PINX rats at ZT24. Insulin efficiently stimulated AKT
phosphorylation in all groups (2.59-fold for SHAM, 2.00-
fold for PINX, and 3.2-fold for PINXMel; P  0.05).
However, insulin-stimulated AKT phosphorylation in
PINX was lower (0.73-fold vs. SHAM; P 0.05) but was
recovered after Mel reposition (Fig. 2C).
Absence of Mel alters night-time expression of
liver FoxO1 and PEPCK
Foxo1 and pepck mRNA expression were assessed in
liver of SHAM and PINX rats during the dark phase of the
L/D cycle, as well as at a representative diurnal ZT (ZT6).
The expression of foxo1mRNA in liver of SHAM rats was
maximal at ZT21, representing more than 3-fold of the
lowest value seen at ZT24 (P 0.05). On the other hand,
foxo1 expression in liver of PINX rats peaked at ZT18
(3-fold increasevs.ZT24;P0.05).Comparing these two
nocturnal profiles, PINX showed values of foxo1 mRNA
expression 1.9-fold higher than SHAM at ZT18 (P 
0.05). At the diurnal ZT6, however, foxo1 expression was
1.2-fold higher in SHAM than in PINX (P  0.05) (Fig.
3A). FoxO1 protein content in PINX at ZT18 was also
higher in SHAM (1.4-fold; P 0.05). Similar to our pre-
FIG. 1. Nocturnal profile of AKT phosphorylation and expression in
liver of SHAM and PINX rats. SHAM (white bars) and PINX (black bars)
rats were housed in 12-h light, 12-h dark cycle under ad libitum
feeding conditions and killed at the indicated ZT times (ZT6, ZT15,
ZT18, ZT21, and ZT24). A fragment of the liver was removed and
processed for immunoblotting detection of phosphoAKT, AKT1, AKT2,
and -actin (A). Data of pAKT (B), AKT1 (C), and AKT2 (D) were
normalized by those of -actin. PINXMel rats (gray bars) were killed
at ZT18, and a fragment of the liver was removed and processed for
immunoblotting detection of pAKT and -actin. In this case, SHAM
and PINX rats killed at ZT18 were treated with vehicle. Data of pAKT
were normalized by those of -actin (E). Results are shown as mean 
SE.*, P  0.05 vs. SHAM at the same ZT; #, P  0.05 vs. SHAM at
ZT24; &, P  0.05 vs. PINX at ZT18; @, P  0.05 vs. PINX at
ZT15 (n  6).
FIG. 2. Gluconeogenesis and insulin-stimulated AKT phosphorylation
in liver of SHAM, PINX, and PINXMel rats. Intraperitoneal PTT was
performed in SHAM, PINX, and PINXMel rats at ZT24. Blood was
collected from the tail before (0 min) and 15, 30, 60, 90, 120, and 150
min after pyruvate injection. SHAM and PINX rats were also pretreated
with 3-mpa (A). The AUC was calculated for each individual animal
within the groups SHAM, PINX, and PINXMel (B). SHAM, PINX, and
PINXMel rats were anesthetized, and a fragment of the liver was
removed at ZT24. Insulin injection was given in the cava vein, and
another liver fragment was removed 30 sec later. Samples were used
for immunoblotting detection of pAKT, AKT1, AKT2, and -actin. Data
of pAKT were normalized by those of -actin (C). Results are shown as
mean  SE. *, P  0.05 vs. SHAM at the same time point after
pyruvate load; #, P  0.05 vs. SHAM; &, P  0.05 vs. basal pAKT
within the same group; @, P  0.05 vs. insulin stimulated pAKT of
SHAM (n  6).
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vious results, Mel treatment resumed FoxO1 content to
SHAM levels (Fig. 3C).
SHAM nocturnal profile of pepck mRNA showed a
monomodal curve peaking at ZT12 (2.9-fold of ZT24
values; P  0.05). In these animals, we also observed a
diurnal increase at ZT6 when compared with ZT24 (2.71-
fold; P  0.05). On the other hand, PINX induced a bi-
modal curve of pepckmRNA peaking at ZT12 and ZT21.
Also, pepck expression was higher in PINX when com-
pared with SHAM at ZT21 and ZT24 (1.80- and 2.40-
fold, respectively; P  0.05) (Fig. 3B). Accordingly, we
found that PEPCK protein content was increased 1.74-
fold in liver of PINX rats when compared with SHAM at
ZT24 (P  0.05). Mel treatment did not restore PEPCK
levels at ZT24 but reduced it when compared with PINX
animals that received the vehicle (0.79-fold the values of
vehicle-treated PINX animals; P  0.05) (Fig. 3D).
Effect of PINX on daily atf6, chop, atf4, bip, perk,
and xbp-1 mRNA profiles
The daily profile of atf6 expression in SHAM rats did
not show a significant variation along the L/D cycle. In
spite of this, the nocturnal expression was smaller than the
diurnal expression (Mann-WhitneyU test;P0.05). This
pattern of daily fluctuation was modified by PINX. PINX
rats showed significant variation along the L/D cycle (P
0.05), and a bimodal pattern of atf6 mRNA was detected
peaking at ZT15 and ZT21. The comparison with SHAM
revealed that PINX animals have increased atf6 expres-
sion at ZT15 (1.70-fold of SHAM values; P  0.05) and
at ZT21 (1.80-fold of SHAM values; P 0.05) (Fig. 4A).
The expression of chop in SHAM rats did not show a
significant variation along the L/D cycle. However, PINX
induced the appearance of a significant variation along the
FIG. 3. Nocturnal profile of pepck and foxo1 expression in liver of
SHAM and PINX rats. SHAM (white bars) and PINX (black bars) rats
were housed in 12-h light, 12-h dark cycle under ad libitum feeding
conditions and killed at the indicated ZT times (ZT6, ZT12, ZT15, ZT18,
ZT21, and ZT24). A fragment of the liver was removed and processed
for total RNA extraction and foxo1 (A) and pepck (B) mRNAs detection
by real-time PCR. SHAM, PINX, and PINXMel (gray bars) were also
killed at ZT18 and ZT24, and a fragment of the liver was removed and
processed for immunoblotting detection of FoxO1 (C) and PEPCK (D),
respectively. In both cases, membranes were probed with -actin,
which was used for data normalization. Results are shown as mean 
SE.*, P  0.05 vs. SHAM at the same ZT; #, P  0.05 vs. SHAM at
ZT24; &, P  0.05 vs. PINX at ZT24; @, P  0.05 vs. PINX at ZT18; $,
P  0.05 vs. PINX at ZT24 (n  6).
FIG. 4. L/D cycle profile of atf6, chop, atf4, bip, perk, and xbp-1
mRNA levels in liver of SHAM and PINX rats. SHAM (lines with circles)
and PINX (lines with triangles) rats were housed in 12-h light, 12-h
dark cycle under ad libitum feeding conditions and killed at the
indicated ZT times (ZT3, ZT6, ZT9, ZT12, ZT15, ZT18, ZT21, and ZT24).
White and black bars indicate, respectively, the light and dark phases
of the L/D cycle. A fragment of the liver was removed and processed
for total RNA extraction and atf6 (A), chop (B), atf4 (C), bip (D), perk
(E), and xbp-1 (F) mRNAs detection by end-point PCR. Results are
shown as mean  SE. *, P  0.05 vs. SHAM at the same ZT; #, P 
0.05 vs. SHAM at ZT9; &, P  0.05 vs. PINX at ZT9 (n  4).
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L/D cycle (P 0.05). Daily chop expression in PINX rats
showed a bimodal pattern peaking at ZT15 and ZT21.
Our data show that chop mRNA was higher in PINX at
ZT15 and ZT21 when compared with SHAM (1.60-
and 1.50-fold of SHAM values, respectively; P  0.05)
(Fig. 4B).
In SHAM rats, atf4 expression reached lowest values in
the middle of the night (ZT18) and at ZT21. Pineal abla-
tion changed the daily profile of atf4mRNA expression to
a bimodal curve peaking at ZT15 and ZT21. Our data
revealed that atf4 mRNA expression in PINX rats was
significantly higher at ZT15 and ZT18 when compared
with SHAM (1.40- and 1.30-fold of SHAM values, re-
spectively; P  0.05) (Fig. 4C).
The mean hepatic bipmRNA expression along the 24 h
of the L/D cycle was higher in PINX when compared with
SHAM rats (P 0.05). This difference was best seen dur-
ing the night and was maximal at ZT21 (1.50-fold of
SHAM; P  0.05). The daily profile of bip expression in
SHAM rats did not show a significant variation along the
L/D cycle. PINX rats, however, showed a daily profile
characterized by a peak at ZT21 (Fig. 4D).
The daily profile of perk expression in
SHAM and PINX rats showed a significant
variation along L/D cycle. The lowest and high-
est levels of perk mRNA expression in SHAM
rats were observed at ZT18 and ZT6, respec-
tively (P  0.05). The diurnal profiles were
similar in SHAM and PINX rats; the only sig-
nificant difference was seen at the ZT6 (P 
0.05) (Fig. 4E).
There was a significant difference between
the 24-h mean of the xbp-1 mRNA expression
in the liver so that PINX values were higher
than those of SHAM (Mann-Whitney U test;
P 0.05). In these two groups, xbp-1 expres-
sion showed a significant variation along the
L/D cycle. The highest expression of xbp-1
mRNA in SHAM rats was observed at ZT24,
whereas in PINX rats, it was phase advanced to
ZT15. As a consequence, xbp-1 expression in
PINX was reduced at ZT24 (0.60-fold of
SHAM values; P  0.05) and increased at
ZT12 and ZT15 when compared with SHAM
rats (1.50- and 1.80-fold of SHAM values, re-
spectively; P  0.05) (Fig. 4F). Splicing of
xbp-1 mRNA was assessed in key time points.
Our data show that in both SHAM and PINX
rats, the splicing of xbp-1 mRNA displayed a
biphasic pattern peaking at ZT12 and ZT24.
However, it was higher in liver of PINX rats at
ZT12 (1.22-fold of SHAM; P  0.05) (Sup-
plemental Fig. 2).
Absence of Mel increases night-time
hepatic CHOP and ATF4 protein content,
and eiF2 phosphorylation
CHOP content reached the highest levels at
ZT21 in SHAM (2.10-fold of ZT15;P0.05).
However, CHOP content at ZT15 and ZT18
was higher in PINX when compared with
SHAM at the same ZT (1.60-fold for both;P
0.05) (Fig. 5A). Administration of Mel to
FIG. 5. Nocturnal profile of CHOP and ATF4 content and eiF2 phosphorylation in
liver of SHAM and PINX rats. SHAM (white bars) and PINX (black bars) rats were
housed in 12-h light, 12-h dark cycle under ad libitum feeding conditions and killed
at the indicated ZT times (ZT15, ZT18, ZT21, and ZT24). A fragment of the liver was
removed and processed for immunoblotting detection of CHOP, ATF4, phospho (p)-
eiF2, and -actin (D). Data of CHOP (A), ATF4 (B), and p-eiF2 (C) were normalized
by those of -actin. PINXMel rats (gray bars) were killed at ZT18, and a fragment
of the liver was removed and processed for immunoblotting detection of CHOP,
ATF4, p-eiF2, and -actin. In this case, SHAM and PINX rats killed at ZT18 were
treated with vehicle (E). Data of CHOP (F), ATF4 (G), and p-eiF2 (H) were
normalized by those of -actin. Results are shown as mean  SE. *, P  0.05 vs.
SHAM at the same ZT; #, P  0.05 vs. SHAM at ZT15; @, P  0.05 vs. SHAM at
ZT24; &, P  0.05 vs. PINX at ZT21 (n  5).
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PINX rats recovered hepatic CHOP content at ZT18 to
values similar that found in SHAM rats (Fig. 5F).
ATF4 content progressively increased in SHAM rats
from ZT15 up to ZT21, followed by a reduction at ZT24
(at ZT21 was 1.73-fold of SHAM at ZT24, P 0.05). In
addition, ATF4 values in PINX rats were higher than in
SHAM at ZT15 and ZT18 (1.70- and 1.40-fold, respec-
tively; P  0.05) (Fig. 5B). Mel reduced hepatic ATF4
content at ZT18 so that its levels became similar to that
found in SHAM (Fig. 5G).
Phosphorylation of eiF2 peaked at ZT21 in SHAM
animals (2.04-fold of ZT15; P 0.05). The highest levels
of eiF2 phosphorylation in PINX rats were phase ad-
vanced to ZT18 (2.80-fold of ZT21; P  0.05). In addi-
tion, eiF2 phosphorylation was higher in PINX than in
SHAM at ZT15 and at ZT18 (2.32- and 2.85-fold, re-
spectively; P  0.05) (Fig. 5C). PINX rats treated with
Mel showed a reduction of eiF2 phosphorylation at
ZT18 so that its levels became similar to that found in
SHAM (Fig. 5H).
Absence of Mel changes hepatic TRB3 and RAPTOR
expression profiles
Expression of trb3 and raptor was assessed in liver of
SHAM and PINX rats during the dark phase of the L/D
cycle and at a representative diurnal ZT (ZT6). Maximal
values of nocturnal trb3mRNA in SHAM rats occurred at
ZT12 (3.40-fold of ZT15; P 0.05). On the other hand,
in PINX rats, maximal values of trb3 was phase delayed,
occurring at ZT18 (1.79-fold of ZT21, P  0.05). In ad-
dition, trb3 mRNA was reduced in PINX at ZT12 (0.67-
fold of SHAM; P  0.05) and increased at ZT18 (1.90-
fold of SHAM; P  0.05). At ZT6, tbr3 expression
increased in both SHAM and PINX when compared with
their counterparts at ZT24 and was higher in SHAM when
comparing with PINX at ZT6 (1.75-fold; P 0.05) (Fig.
6A). TRB3 protein content was also increased in liver of
PINX rats at ZT18 when compared with SHAM animals
(1.56-fold; P  0.05). Moreover, supplementation with
Mel reduced hepatic TRB3 content in PINX rats at ZT18
in such way that it reached values similar to that found in
SHAM (Fig. 6D).
Expression of raptor mRNA peaked at ZT6 in SHAM
rats (5.04-fold of ZT24; P 0.05) and at ZT18 in PINX
rats (2.00-fold of ZT24; P  0.05). PINX by itself in-
creased raptor mRNA at ZT12, ZT15, ZT18, and ZT24
when compared with their respective SHAM counterparts
(1.30-, 1.50-, 1.53-, and 2.25-fold, respectively;P 0.05)
but decreased it at ZT6 (0.55-fold of SHAM at ZT6) (Fig.
6B). We have also found that PINX increased hepatic
RAPTOR content at ZT18 (1.66-fold the values of
SHAM; P 0.05) and Mel reposition reduced it (Fig. 6E).
PBA treatment improves hepatic insulin action and
decreases gluconeogenesis in PINX at ZT24
As shown in Fig. 2A, PINX rats exhibited a higher in-
crease in glucose levels after a pyruvate load when com-
pared with SHAM animals. PINX rats treated with PBA,
a chemical chaperone known to inhibit UPR, exhibited
values of glycemia after pyruvate injection similar to that
found in SHAM (Fig. 7A). The AUC of PINX rats (2.55-
fold values of that of SHAM; P  0.05) was completely
abrogated by treatment of PINX rats with PBA (Fig. 7B).
No changes in basal AKT phosphorylation were found
when comparing SHAM and PINX, but PBA reduced
basal AKT phosphorylation of PINX rats (0.30-fold val-
ues of basal PINX; P  0.05). In addition, insulin effi-
ciently stimulated AKT phosphorylation in all groups
(2.34-fold of respective basal for SHAM, 1.83-fold of re-
spective basal for PINX, and 8.39-fold of respective basal
for PINX treated with PBA;P0.05). Insulin-stimulated
AKT phosphorylation in PINX rats was lower than that
of SHAM animals (0.66-fold of insulin-stimulated
FIG. 6. Nocturnal profile of trb3 and raptor expression in liver of
SHAM and PINX rats. SHAM (white bars) and PINX (black bars) rats
were housed in 12-h light, 12-h dark cycle under ad libitum feeding
conditions and killed at the indicated ZT times (ZT6, ZT12, ZT15, ZT18,
ZT21, and ZT24). A fragment of the liver was removed and processed
for total RNA extraction and trb3 (A) and raptor (B) mRNAs detection
by real-time PCR. SHAM, PINX, and PINXMel rats (gray bars) were
also killed at ZT18, and a fragment of the liver was removed and
processed for immunoblotting detection of TRB3, RAPTOR, and -
actin. In this case, SHAM and PINX rats were treated with vehicle (C).
Data of TRB3 (D) and RAPTOR (E) were normalized by those of -actin.
Results are shown as mean  SEM. *, P  0.05 vs. SHAM at the same
ZT; #, P  0.05 vs. SHAM at ZT15; &, P  0.05 vs. PINX at ZT21; @,
P  0.05 vs. SHAM at ZT24; $, P  0.05 vs. PINX at ZT24 (n  4).
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SHAM; P  0.05). Insulin-stimulated AKT phosphor-
ylation values in PINX rats were recovered to values
similar to that found in SHAM animals after treatment
with PBA (Fig. 7C).
Discussion
Pineal gland removal is known to result in glucose in-
tolerance by inducing insulin resistance (1). Because a
reduced insulin-stimulated glucose uptake by adi-
pocytes of PINX rats occurs independently of the L/D
cycle (2), this alteration would not explain the specific
increase in night-time circulating glucose values de-
tected after PINX (3).
The daily rhythm of hepatic PEPCK expres-
sion and blood glucose levels have been dem-
onstrated to be generated by both nocturnal
feeding behavior and oscillations in sympa-
thetic and parasympathetic inputs from the
central nervous system to the liver. These con-
clusions came from studies showing that com-
plete hepatic denervation combined with a
noncircadian feeding regimen abolished the
night-time reduction in PEPCK expression (6,
7). Our present data add relevant information
to the literature in such way that it describes a
hormonal signal to the liver that modulates the
circadian rhythm of PEPCK. Thus, we do not
propose that Mel generates the circadian
rhythm of PEPCK but collaborates to keep he-
patic PEPCK levels down-regulated until the
end of the dark phase.
The most accepted intracellular mechanism
that explains how activation of AKT by insulin
suppresses PEPCK expression involves FoxO1
phosphorylation (20). FoxO1 is a transcrip-
tional factor that binds to the promoter region
of the PEPCK gene and enhances its transcrip-
tion (21). Once phosphorylated by AKT,
FoxO1 translocation to the nucleus is inhib-
ited, resulting in its accumulation in the cyto-
plasm (21).
We have found increased foxo1 in SHAM
animals at ZT21, which is probably contrib-
uting to a posterior increase of pepck expres-
sion at the diurnal ZT6. In PINX animals, the
increase of foxo1 was phase advanced to
ZT18, which is probably contributing to the
early increase inpepck at ZT24. Reduced basal
AKT phosphorylation was also detected in
PINX rats at ZT18 and, thus, preceding the
increased pepck. Considering this, our results
suggest that the absence of Mel promotes a phase advance
in the night-time increase of foxo1 with a parallel reduc-
tion of AKT phosphorylation (at ZT18). These events pos-
sibly favor the increased pepck expression in the dark-
phase (ZT21 and ZT24). Favoring the hypothesis that Mel
might facilitate hepatic night-time insulin action, Mel re-
ceptors were shown to be expressed in rat liver (22), and
Mel treatment was described to activate AKT in vivo (23)
and in vitro (24). However, because PINX rats have higher
corticosterone levels (2), we cannot discard that glucocor-
ticoids may contribute to the hepatic insulin resistance.
To confirm whether these changes would correlate with
proper insulin resistance and increased gluconeogenesis in
PINX at the end of the night, we next investigated insulin-
FIG. 7. Gluconeogenesis and insulin-stimulated AKT phosphorylation in liver of
SHAM, PINX, and PINXPBA rats. Intraperitoneal PTT was performed in SHAM,
PINX, and PINXPBA rats at ZT24. Blood was collected from the tail before (0 min)
and 15, 30, 60, 90, 120, and 150 min after pyruvate injection (A). The AUC was
calculated for each individual animal (B). SHAM, PINX, and PINXPBA rats were
anesthetized, and a fragment of the liver was removed at ZT24. Insulin injection was
given in the cava vein, and another liver fragment was removed 30 sec later.
Samples were used for immunoblotting detection of pAKT, AKT1, AKT2, and -
actin. Data of pAKT was normalized by those of -actin (C). Results are shown as
mean  SE. *, P  0.05 vs. SHAM at the same time point after pyruvate load; #, P 
0.05 vs. SHAM; &, P  0.05 vs. basal pAKT within the same group; @, P  0.05 vs.
insulin stimulated pAKT of SHAM; $, P  0.05 vs. basal phosphoAKT of PINX (n 
6). CTL, Control.
1260 Nogueira et al. PINX and Nocturnal Hepatic UPR Endocrinology, April 2011, 152(4):1253–1263
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 24 February 2015. at 08:35 For personal use only. No other uses without permission. . All rights reserved.
stimulated hepatic AKT phosphorylation and whole body
gluconeogenesis. Concordantly with increased PEPCK ex-
pression at ZT24, liver of PINX rats displayed insulin-
resistance as evidenced by reduced insulin-stimulated
AKT phosphorylation. The physiological relevance of this
alteration was characterized by increased conversion of
pyruvate to glucose. In this way, insulin, which is normally
high in nocturnal feeding periods, probably does not ef-
fectively repress PEPCK and gluconeogenesis in liver of
PINX rats. These alterations found in PINX rats are prob-
ably due to the absence of Mel, because Mel supplemen-
tation reduced PEPCK and gluconeogenesis and increased
insulin-stimulated AKT phosphorylation. It is important
to note that the night-time hepatic insulin resistance with
concomitant increased gluconeogenesis in PINX rats was
achieved without changes in body weight and adiposity
(Supplemental Table 3).
Attempting to clarify the mechanisms leading to night-
time hepatic insulin resistance in liver of PINX rats, we
investigated the circadian variation of UPR activation, be-
cause this response is being currently considered a crucial
event that contributes to insulin resistance throughout the
establishment of type 2 diabetes mellitus (11, 25).
Activation of UPR is triggered by the dissociation of the
chaperone BiP from the transducer proteins PERK, ATF6
and inositol-requiring protein 1 (IRE1). IRE1 activation
targets alternative splicing of xbp1 mRNA. In mammal
cells, processed xbp1 mRNA originates an active tran-
scription factor that facilitates the expression of several
enzymes that promote ER-associated degradation of mis-
folded proteins (26). ATF6 pathway is somehow redun-
dant to that of IRE1/X-box binding protein 1 but also
potentiates IRE1 pathway by increasing the transcription
xbp1 gene (27). PERK activation, in turn, targets eIF2
phosphorylation, which contributes to attenuation of
mRNA translation (9).
UPR activation has been described to generate insulin
resistance in skeletal muscle and adipose tissue (25, 28).
Regarding the liver, long- and short-term activation of the
UPR pathways with thapsigargin cause hepatic insulin re-
sistance and stimulate glucose production by gluconeo-
genesis in vivo (13) and correlate with increased PEPCK
expression in vitro (14). However, the simple affirmation
that UPR activation stimulates gluconeogenesis and he-
patic insulin resistance is probably not true. Although
ATF6 knockout mice develop lower levels of glycemia and
reduced PEPCK expression in the liver, these animals are
hypersensitive to glucagon-induced gluconeogenesis (29).
In this way, the duration of the stress response seems to
determine whether UPR will stimulate or inhibit gluco-
neogenesis by the hepatocyte. Seo et al. (14) have demon-
strated that acute stimulation with thapsigargin rapidly
stimulates ER stress, which favors PEPCK and glucose-6-
phosphatase expression. If UPR activation persists, these
authors show that the response switches to an inhibition
over gluconeogenic enzymes (14). Another independent
group has also demonstrated that short-term activation of
UPR with chemical agents increases glucose output from
hepatic cells (30). Therefore, the current knowledge sug-
gests that a broad and transitory activation of the UPR,
rather than chronic activation, favors PEPCK expression
and stimulates gluconeogenesis. Importantly, we have
found that atf4, atf6, chop, and bip expression and eiF2
phosphorylation are up-regulated in liver of PINX rats
during intermediary nocturnal time points of the L/D cy-
cle. We have also found increased xbp-1 splicing in PINX
rats at the transition from the light to the dark phase
(ZT12) (Supplemental Fig. 2). Thus, it is possible that the
oscillatory pattern of UPR activation in liver of PINX rats
(what confers a short-term nature) might culminate in in-
creased gluconeogenesis and insulin resistance found at
the end of the dark-phase.
To test this hypothesis, we next measured gluconeo-
genesis and insulin-stimulated AKT phosphorylation in
liver of PINX rats treated with PBA, a short chain fatty
acid described as a chemical chaperone because of its abil-
ity to stabilize protein conformation, to improve ER fold-
ing capacity, and to facilitate the trafficking of mutant
FIG. 8. Diagram representing the proposed model for night-time
insulin resistance in liver of PINX rats. AKT, Ras-like protein TC25-
serine/threonine kinase. pAKT, PhosphoAKT.
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proteins (31). Importantly, PBA was already demon-
strated to inhibit ER stress and improve glucose intoler-
ance by enhancing AKT phosphorylation in liver (32).
Favoring the proposition that UPR might cope with insu-
lin resistance and increased gluconeogenesis in liver of
PINX rats at the end of the night feeding period, our data
show that PBA treatment restores insulin-stimulated AKT
phosphorylation in PINX rats and reduces pyruvate con-
version to glucose.
TRB3, a pseudo kinase inhibitor of AKT, is a prominent
candidate to link UPR to hepatic insulin resistance. Con-
vergent data have shown that increased TRB3 expression
in liver of insulin-resistant mice abrogates AKT phosphor-
ylation and stimulates gluconeogenesis (33). In agree-
ment with these findings, we found that trb3 mRNA
expression increases at ZT18 in PINX rats, which cor-
relates with a reduction in AKT phosphorylation. Im-
portantly, Mel supplementation reduced TRB3 protein
levels in liver of PINX rats.
UPR stimulation of TRB3 expression was demon-
strated to be mediated by a heterodimer formed by ATF4
and CHOP (34). In accordance with this mechanism, we
found that the absence o Mel elicits a simultaneous in-
crease of ATF4 and CHOP at ZT15, which precedes the
simultaneous raise in TRB3 and the fall in AKT phosphor-
ylation at ZT18. Altogether, our results suggest that the
absence of pineal Mel results in an increase of CHOP/
ATF4 at ZT15, which, in turn, induces TRB3 expression
at ZT18 that will reflect on hepatic insulin resistance fully
established at ZT24 (characterized by reduced insulin-
stimulated AKT phosphorylation and increased PEPCK
and gluconeogenesis).
AKT phosphorylation status is regulated by a myriad of
proteins that are beyond the UPR-induced TRB3 expres-
sion. For instance, AKT is negatively regulated by RAP-
TOR, a protein that is able to bind to mTOR forming a
complex known as transducer of regulated cAMP re-
sponse element 1 (35). In liver, forced expression of a non-
functional RAPTOR was described to increase AKT phos-
phorylation (36). Our results show a consonant increase
of raptor mRNA in liver of PINX rats at ZT18. In addi-
tion, raptor expression is increased in PINX rats at almost
all nocturnal ZTs, including ZT24, when insulin resis-
tance was actually detected. Thus, we hypothesize that,
together with increased TRB3 expression, an increase in
RAPTOR favors the reduction of AKT phosphorylation in
liver of PINX rats at the end of the night.
Besides the hepatic night-time insulin resistance in-
duced by PINX, the present data reveal that the absence of
Mel causes a putative desynchronization of the gluconeo-
genic state of the liver from feeding status. As seen in
SHAM animals, pepck expression increases at the diurnal
ZT6 comparing with the last nocturnal time point and
reaches a maximum at ZT12 just prior lights off. This
increase in pepck parallels the minimal diurnal food in-
take of SHAM animals, being almost all food intake
occurring during the night (when pepck expression is pro-
gressively repressed). Exactly as for SHAM, PINX main-
tained this preferential nocturnal food behavior (Supple-
mental Fig. 1), but in these animals, hepatic pepck tends to
diminish as they went from ZT24 to ZT6. Our inter-
pretation is that the absence of Mel might impair glu-
cose metabolism not only by causing insulin resistance
but also by disrupting the entrainment of food intake
and hepatic glucose production. Favoring this hypoth-
esis, PINX rats show reduced hepatic trb3, foxo1, and
raptor expression at ZT6. We would like to stress, how-
ever, that this desynchronization remains to be consis-
tently demonstrated.
In summary, this work shows that the absence of Mel
prompts hepatic insulin resistance at the end of the night
feeding period, highlighted by reduced insulin-stimulated
AKT phosphorylation and increased gluconeogenesis and
PEPCK expression. This phenomenon is probably a result
of UPR activation and stimulation of trb3 expression dur-
ing intermediary hours of the dark phase of L/D cycle
(ranging from ZT15 to ZT21). Moreover, increased ex-
pression of RAPTOR is also likely to contribute to insulin
resistance. A summary diagram of our data is shown in
Fig. 8. To our knowledge, this study is the first to report
circadian alterations in hepatic UPR activation and to re-
late these changes with Mel absence and night-time insulin
resistance.
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